In the last trading session, 2.05 million Atyr Pharma Inc (NASDAQ:ATYR) shares changed hands as the company’s beta touched 0.84. With the company’s per share price at $4.01 changed hands at $0.04 or 1.01% during last session, the market valuation stood at $356.32M. ATYR’s last price was a discount, traded about -16.21% off its 52-week high of $4.66. The share price had its 52-week low at $1.42, which suggests the last value was 64.59% up since then. When we look at Atyr Pharma Inc’s average trading volume, we note the 10-day average is 2.15 million shares, with the 3-month average coming to 1.25 million.
Atyr Pharma Inc (NASDAQ:ATYR) trade information
Instantly ATYR was in green as seen at the end of in last trading. With action 29.35%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 10.77%, with the 5-day performance at 29.35% in the green. However, in the 30-day time frame, Atyr Pharma Inc (NASDAQ:ATYR) is 11.70% up. Looking at the short shares, we see there were 5.26 million shares sold at short interest cover period of 4.17 days.
Atyr Pharma Inc (ATYR) estimates and forecasts
Year-over-year growth is forecast to reach 751.06% up from the last financial year.
The company’s revenue for the corresponding quarters a year ago was 235k. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -100.00%. The estimates for the next quarter sales put growth at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 43.36%. The 2025 estimates are for Atyr Pharma Inc earnings to increase by 13.42%.
ATYR Dividends
Atyr Pharma Inc is expected to release its next quarterly earnings report on 2025-Mar-12.
Atyr Pharma Inc (NASDAQ:ATYR)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 2.16% of Atyr Pharma Inc shares while 65.54% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 66.98%.
Among Mutual Funds, the top two as of Oct 31, 2024 were Federated Hermes Kaufmann Fund and Federated Hermes Kaufmann Small Cap Fund . With 7.85 shares estimated at $31.48 million under it, the former controlled 8.83% of total outstanding shares. On the other hand, Federated Hermes Kaufmann Small Cap Fund held about 7.45% of the shares, roughly 6.62 shares worth around $26.55 million.
